Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
CLEO Diagnostics Ltd ( (AU:COV) ) has provided an update.
Cleo Diagnostics Ltd announced the successful outcomes of its Annual General Meeting, where all proposed resolutions were passed. This includes the re-election of directors and the approval of a 10% placement facility and an employee securities incentive plan, indicating strong shareholder support and potential for future strategic growth.
The most recent analyst rating on (AU:COV) stock is a Buy with a A$1.15 price target. To see the full list of analyst forecasts on CLEO Diagnostics Ltd stock, see the AU:COV Stock Forecast page.
More about CLEO Diagnostics Ltd
Cleo Diagnostics Ltd operates in the medical diagnostics industry, focusing on developing innovative diagnostic solutions. The company is listed on the Australian Securities Exchange under the ticker ASX:COV.
Average Trading Volume: 235,841
Technical Sentiment Signal: Buy
Current Market Cap: A$82.88M
For a thorough assessment of COV stock, go to TipRanks’ Stock Analysis page.